Recent Finacing
Recent Raise
GenrAb discovers and develops fully human neuroprotective antibodies from patient cerebrospinal fluid using proprietary immunogenetic models, advancing BBB‑penetrant candidates that internalize into neurons and modulate neuronal stress pathways.
